Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,787,809
+$1,296,958 QoQ
Shares Held
574,806
-9.8% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 114 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. ZNTL ranks #94 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6
659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in ZNTL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,787,809 574,806
2026-03-31 $1,490,851 637,116
2025-12-31 $23,585 17,471
2025-09-30 $85,524 56,639
2025-06-30 $37,251 32,113
2023-12-31 $760,560 50,202
2023-09-30 $2,836,243 141,388
2022-03-31 $700,266 15,177
2021-12-31 $740,904 8,814
2021-09-30 $628,681 9,434
2021-06-30 $291,802 5,485